BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10166801)

  • 1. Loss of bronchodilator medication in priming a conventional metered dose inhaler: a cost of treating asthma.
    Ross RN
    Med Interface; 1997 Apr; 10(4):141-6. PubMed ID: 10166801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalers.
    Langley PC
    Clin Ther; 1999 Jan; 21(1):236-53. PubMed ID: 10090438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review and economic evaluation of bronchodilator delivery methods in hospitalized patients.
    Turner MO; Gafni A; Swan D; FitzGerald JM
    Arch Intern Med; 1996 Oct; 156(18):2113-8. PubMed ID: 8862104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metered dose inhaler therapy for asthma, bronchitis, and emphysema.
    Hofford JM
    J Fam Pract; 1992 Apr; 34(4):485-92. PubMed ID: 1556541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could interchangeable use of dry powder inhalers affect patients?
    Price D; Summers M; Zanen P
    Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device.
    Donnell D
    Eur Rev Med Pharmacol Sci; 2001; 5(1):7-16. PubMed ID: 11860222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness analysis of breath-actuated metered-dose inhalers.
    Kelloway JS; Wyatt R
    Manag Care Interface; 1997 Sep; 10(9):99-107. PubMed ID: 10175551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience.
    Salyer JW; DiBlasi RM; Crotwell DN; Cowan CA; Carter ER
    Respir Care; 2008 Mar; 53(3):338-45. PubMed ID: 18291050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budesonide turbuhaler for asthma.
    Med Lett Drugs Ther; 1998 Jan; 40(1018):15-6. PubMed ID: 9457158
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
    von Berg A; Jeena PM; Soemantri PA; Vertruyen A; Schmidt P; Gerken F; Razzouk H
    Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems with inhaler use: a call for improved clinician and patient education.
    Fink JB; Rubin BK
    Respir Care; 2005 Oct; 50(10):1360-74; discussion 1374-5. PubMed ID: 16185371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of non-chlorofluorocarbon-containing salbutamol and conventional inhaler.
    Desager KN; van Bever HP; Vermeire PA
    Lancet; 1996 Jul; 348(9021):200-1. PubMed ID: 8684181
    [No Abstract]   [Full Text] [Related]  

  • 17. The evolution of inhaler technology.
    Grossman J
    J Asthma; 1994; 31(1):55-64. PubMed ID: 8175626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler.
    Hodder R; Pavia D; Dewberry H; Alexander K; Iacono P; Ponitz H; Beck E
    Respir Med; 2005 Sep; 99(9):1087-95. PubMed ID: 15893465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost impact of metered dose inhalers vs small volume nebulizers in hospitalized patients: the Cleveland Clinic experience.
    Orens DK; Kester L; Fergus LC; Stoller JK
    Respir Care; 1991 Oct; 36(10):1099-114. PubMed ID: 10145565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of inhaler devices in the management of airway disease.
    Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
    Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.